Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIV4 vs IIV4 in Pregnant Women
NCT03969641Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Duke University. Started Sep 2019; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03969641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03969641.